Background
==========

We reported previously that alveolar macrophages from scleroderma patients with lung inflammation are characterized by an activated gene expression profile.

Objective
=========

The purpose of this study was to identify the molecular mediators that have activated alveolar macrophages in scleroderma lung disease, through an analysis of transcription factor activation.

Methods
=======

Freshly isolated alveolar macrophages were negatively selected by depleting CD3^+^ cells from BAL cells of six patients with lung inflammation. Nuclear translocation of 55 transcription factors was evaluated using a protein/DNA array system (Panomics). Data were analyzed using hierarchical clustering.

Results and conclusion
======================

Three distinct clusters of translocated transcription factors were notable. One cluster included Smad3/4 as well as other factors involved in or activated by TGF-β signaling, including CREB/p300, Fast-1, the glucocorticoid receptor element, and GAS/ISRE. A second cluster included Stat5/6 and other factors activated by IL-4 signaling, including GATA, Sp1, and early-response element. The third cluster included factors that were translocated to the nucleus in low levels in only a few samples. This cluster included NF-κB, which is critical in signaling by TNF-α and IL-1, and several other transcription factors activated by TNF-α signaling. In animal models, macrophages that are activated by TGF-β or IL-4 have been associated with the subsequent development of fibrosis. Thus, we directly demonstrate cellular activation by the profibrotic factors TGF-β and IL-4 in involved tissues from scleroderma patients.
